 | • レポートコード：GIR201105948 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、オベチコール酸薬の世界市場を調査対象にし、オベチコール酸薬の市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（5mg、10mg）、用途別分析（原発性胆汁性肝硬変、非アルコール性脂肪肝疾患、その他）、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：Intercept Pharmaceuticals、Dainippon Sumitomo Pharma ・メーカー別販売量、売上、市場シェア ・オベチコール酸薬の地域別市場分析 ・オベチコール酸薬の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・オベチコール酸薬のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・オベチコール酸薬のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・オベチコール酸薬の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・オベチコール酸薬の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・オベチコール酸薬の種類別市場規模2015-2020：5mg、10mg ・オベチコール酸薬の用途別市場規模2015-2020：原発性胆汁性肝硬変、非アルコール性脂肪肝疾患、その他 ・オベチコール酸薬の世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The global Obeticholic Acid Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Obeticholic Acid Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Obeticholic Acid Drug market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Obeticholic Acid Drug market has been segmented into
5mg
10mg
By Application, Obeticholic Acid Drug has been segmented into:
Primary Biliary Cirrhosis
Nonalcoholic Fatty Liver Disease
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Obeticholic Acid Drug market presented in the report. This section sheds light on the sales growth of different regional and country-level Obeticholic Acid Drug markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Obeticholic Acid Drug market.
The report offers in-depth assessment of the growth and other aspects of the Obeticholic Acid Drug market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Obeticholic Acid Drug Market Share Analysis
Obeticholic Acid Drug competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Obeticholic Acid Drug sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Obeticholic Acid Drug sales, revenue and market share for each player covered in this report.
The major players covered in Obeticholic Acid Drug are:
Intercept Pharmaceuticals
Dainippon Sumitomo Pharma
Among other players domestic and global, Obeticholic Acid Drug market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Obeticholic Acid Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Obeticholic Acid Drug, with price, sales, revenue and global market share of Obeticholic Acid Drug in 2018 and 2019.
Chapter 3, the Obeticholic Acid Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Obeticholic Acid Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Obeticholic Acid Drug market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Obeticholic Acid Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Obeticholic Acid Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Obeticholic Acid Drug Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 5mg
1.2.3 10mg
1.3 Market Analysis by Application
1.3.1 Overview: Global Obeticholic Acid Drug Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Primary Biliary Cirrhosis
1.3.3 Nonalcoholic Fatty Liver Disease
1.3.4 Other
1.4 Overview of Global Obeticholic Acid Drug Market
1.4.1 Global Obeticholic Acid Drug Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Intercept Pharmaceuticals
2.1.1 Intercept Pharmaceuticals Details
2.1.2 Intercept Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Intercept Pharmaceuticals SWOT Analysis
2.1.4 Intercept Pharmaceuticals Product and Services
2.1.5 Intercept Pharmaceuticals Obeticholic Acid Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Dainippon Sumitomo Pharma
2.2.1 Dainippon Sumitomo Pharma Details
2.2.2 Dainippon Sumitomo Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Dainippon Sumitomo Pharma SWOT Analysis
2.2.4 Dainippon Sumitomo Pharma Product and Services
2.2.5 Dainippon Sumitomo Pharma Obeticholic Acid Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Obeticholic Acid Drug Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Obeticholic Acid Drug Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Obeticholic Acid Drug Manufacturer Market Share in 2019
3.3.2 Top 6 Obeticholic Acid Drug Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Obeticholic Acid Drug Sales, Revenue and Market Share by Regions
4.1.1 Global Obeticholic Acid Drug Sales and Market Share by Regions (2015-2020)
4.1.2 Global Obeticholic Acid Drug Revenue and Market Share by Regions (2015-2020)
4.2 North America Obeticholic Acid Drug Sales and Growth Rate (2015-2020)
4.3 Europe Obeticholic Acid Drug Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Obeticholic Acid Drug Sales and Growth Rate (2015-2020)
4.5 South America Obeticholic Acid Drug Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Obeticholic Acid Drug Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Obeticholic Acid Drug Sales, Revenue and Market Share by Country
5.1.1 North America Obeticholic Acid Drug Sales and Market Share by Country (2015-2020)
5.1.2 North America Obeticholic Acid Drug Revenue and Market Share by Country (2015-2020)
5.2 United States Obeticholic Acid Drug Sales and Growth Rate (2015-2020)
5.3 Canada Obeticholic Acid Drug Sales and Growth Rate (2015-2020)
5.4 Mexico Obeticholic Acid Drug Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Obeticholic Acid Drug Sales, Revenue and Market Share by Country
6.1.1 Europe Obeticholic Acid Drug Sales and Market Share by Country (2015-2020)
6.1.2 Europe Obeticholic Acid Drug Revenue and Market Share by Country (2015-2020)
6.2 Germany Obeticholic Acid Drug Sales and Growth Rate (2015-2020)
6.3 UK Obeticholic Acid Drug Sales and Growth Rate (2015-2020)
6.4 France Obeticholic Acid Drug Sales and Growth Rate (2015-2020)
6.5 Russia Obeticholic Acid Drug Sales and Growth Rate (2015-2020)
6.6 Italy Obeticholic Acid Drug Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Obeticholic Acid Drug Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Obeticholic Acid Drug Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Obeticholic Acid Drug Revenue and Market Share by Regions (2015-2020)
7.2 China Obeticholic Acid Drug Sales and Growth Rate (2015-2020)
7.3 Japan Obeticholic Acid Drug Sales and Growth Rate (2015-2020)
7.4 Korea Obeticholic Acid Drug Sales and Growth Rate (2015-2020)
7.5 India Obeticholic Acid Drug Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Obeticholic Acid Drug Sales and Growth Rate (2015-2020)
7.7 Australia Obeticholic Acid Drug Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Obeticholic Acid Drug Sales, Revenue and Market Share by Country
8.1.1 South America Obeticholic Acid Drug Sales and Market Share by Country (2015-2020)
8.1.2 South America Obeticholic Acid Drug Revenue and Market Share by Country (2015-2020)
8.2 Brazil Obeticholic Acid Drug Sales and Growth Rate (2015-2020)
8.3 Argentina Obeticholic Acid Drug Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Obeticholic Acid Drug Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Obeticholic Acid Drug Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Obeticholic Acid Drug Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Obeticholic Acid Drug Sales and Growth Rate (2015-2020)
9.3 Turkey Obeticholic Acid Drug Sales and Growth Rate (2015-2020)
9.4 Egypt Obeticholic Acid Drug Sales and Growth Rate (2015-2020)
9.5 South Africa Obeticholic Acid Drug Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Obeticholic Acid Drug Sales and Market Share by Type (2015-2020)
10.2 Global Obeticholic Acid Drug Revenue and Market Share by Type (2015-2020)
10.3 Global Obeticholic Acid Drug Price by Type (2015-2020)
11 Global Obeticholic Acid Drug Market Segment by Application
11.1 Global Obeticholic Acid Drug Sales Market Share by Application (2015-2020)
11.2 Global Obeticholic Acid Drug Revenue Market Share by Application (2015-2020)
11.3 Global Obeticholic Acid Drug Price by Application (2015-2020)
12 Market Forecast
12.1 Global Obeticholic Acid Drug Sales, Revenue and Growth Rate (2021-2025)
12.2 Obeticholic Acid Drug Market Forecast by Regions (2021-2025)
12.2.1 North America Obeticholic Acid Drug Market Forecast (2021-2025)
12.2.2 Europe Obeticholic Acid Drug Market Forecast (2021-2025)
12.2.3 Asia-Pacific Obeticholic Acid Drug Market Forecast (2021-2025)
12.2.4 South America Obeticholic Acid Drug Market Forecast (2021-2025)
12.2.5 Middle East & Africa Obeticholic Acid Drug Market Forecast (2021-2025)
12.3 Obeticholic Acid Drug Market Forecast by Type (2021-2025)
12.3.1 Global Obeticholic Acid Drug Sales Forecast by Type (2021-2025)
12.3.2 Global Obeticholic Acid Drug Market Share Forecast by Type (2021-2025)
12.4 Obeticholic Acid Drug Market Forecast by Application (2021-2025)
12.4.1 Global Obeticholic Acid Drug Sales Forecast by Application (2021-2025)
12.4.2 Global Obeticholic Acid Drug Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Obeticholic Acid Drug Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Obeticholic Acid Drug by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Obeticholic Acid Drug Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Intercept Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 8. Intercept Pharmaceuticals Obeticholic Acid Drug Major Business
Table 9. Intercept Pharmaceuticals Obeticholic Acid Drug Total Revenue (USD Million) (2017-2018)
Table 10. Intercept Pharmaceuticals SWOT Analysis
Table 11. Intercept Pharmaceuticals Obeticholic Acid Drug Product and Services
Table 12. Intercept Pharmaceuticals Obeticholic Acid Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Dainippon Sumitomo Pharma Basic Information, Manufacturing Base and Competitors
Table 14. Dainippon Sumitomo Pharma Obeticholic Acid Drug Major Business
Table 15. Dainippon Sumitomo Pharma Obeticholic Acid Drug Total Revenue (USD Million) (2017-2018)
Table 16. Dainippon Sumitomo Pharma SWOT Analysis
Table 17. Dainippon Sumitomo Pharma Obeticholic Acid Drug Product and Services
Table 18. Dainippon Sumitomo Pharma Obeticholic Acid Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Global Obeticholic Acid Drug Sales by Manufacturer (2018-2019) (K Units)
Table 20. Global Obeticholic Acid Drug Revenue by Manufacturer (2018-2019) (USD Million)
Table 21. Global Obeticholic Acid Drug Sales by Regions (2015-2020) (K Units)
Table 22. Global Obeticholic Acid Drug Sales Market Share by Regions (2015-2020)
Table 23. Global Obeticholic Acid Drug Revenue by Regions (2015-2020) (USD Million)
Table 24. North America Obeticholic Acid Drug Sales by Countries (2015-2020) (K Units)
Table 25. North America Obeticholic Acid Drug Sales Market Share by Countries (2015-2020)
Table 26. North America Obeticholic Acid Drug Revenue by Countries (2015-2020) (USD Million)
Table 27. North America Obeticholic Acid Drug Revenue Market Share by Countries (2015-2020)
Table 28. Europe Obeticholic Acid Drug Sales by Countries (2015-2020) (K Units)
Table 29. Europe Obeticholic Acid Drug Sales Market Share by Countries (2015-2020)
Table 30. Europe Obeticholic Acid Drug Revenue by Countries (2015-2020) (USD Million)
Table 31. Asia-Pacific Obeticholic Acid Drug Sales by Regions (2015-2020) (K Units)
Table 32. Asia-Pacific Obeticholic Acid Drug Sales Market Share by Regions (2015-2020)
Table 33. Asia-Pacific Obeticholic Acid Drug Revenue by Regions (2015-2020) (USD Million)
Table 34. South America Obeticholic Acid Drug Sales by Countries (2015-2020) (K Units)
Table 35. South America Obeticholic Acid Drug Sales Market Share by Countries (2015-2020)
Table 36. South America Obeticholic Acid Drug Revenue by Countries (2015-2020) (USD Million)
Table 37. South America Obeticholic Acid Drug Revenue Market Share by Countries (2015-2020)
Table 38. Middle East & Africa Obeticholic Acid Drug Sales by Countries (2015-2020) (K Units)
Table 39. Middle East & Africa Obeticholic Acid Drug Sales Market Share by Countries (2015-2020)
Table 40. Middle East & Africa Obeticholic Acid Drug Revenue by Countries (2015-2020) (USD Million)
Table 41. Middle East & Africa Obeticholic Acid Drug Revenue Market Share by Countries (2015-2020)
Table 42. Global Obeticholic Acid Drug Sales by Type (2015-2020) (K Units)
Table 43. Global Obeticholic Acid Drug Sales Share by Type (2015-2020)
Table 44. Global Obeticholic Acid Drug Revenue by Type (2015-2020) (USD Million)
Table 45. Global Obeticholic Acid Drug Revenue Share by Type (2015-2020)
Table 46. Global Obeticholic Acid Drug Sales by Application (2015-2020) (K Units)
Table 47. Global Obeticholic Acid Drug Sales Share by Application (2015-2020)
Table 48. Global Obeticholic Acid Drug Sales Forecast by Regions (2021-2025) (K Units)
Table 49. Global Obeticholic Acid Drug Market Share Forecast by Regions (2021-2025)
Table 50. Global Obeticholic Acid Drug Sales Forecast by Type (2021-2025) (K Units)
Table 51. Global Obeticholic Acid Drug Market Share Forecast by Type (2021-2025)
Table 52. Global Obeticholic Acid Drug Sales Forecast by Application (2021-2025)
Table 53. Global Obeticholic Acid Drug Market Share Forecast by Application (2021-2025)
Table 54. Direct Channel Pros & Cons
Table 55. Indirect Channel Pros & Cons
Table 56. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Obeticholic Acid Drug Picture
Figure 2. Global Sales Market Share of Obeticholic Acid Drug by Type in 2019
Figure 3. 5mg Picture
Figure 4. 10mg Picture
Figure 5. Obeticholic Acid Drug Sales Market Share by Application in 2018
Figure 6. Primary Biliary Cirrhosis Picture
Figure 7. Nonalcoholic Fatty Liver Disease Picture
Figure 8. Other Picture
Figure 9. Global Obeticholic Acid Drug Market Status and Outlook (2015-2025) (USD Million)
Figure 10. United States Obeticholic Acid Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Canada Obeticholic Acid Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Mexico Obeticholic Acid Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Germany Obeticholic Acid Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 14. France Obeticholic Acid Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 15. UK Obeticholic Acid Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Russia Obeticholic Acid Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Italy Obeticholic Acid Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 18. China Obeticholic Acid Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Japan Obeticholic Acid Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Korea Obeticholic Acid Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 21. India Obeticholic Acid Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Southeast Asia Obeticholic Acid Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Australia Obeticholic Acid Drug Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 24. Brazil Obeticholic Acid Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Egypt Obeticholic Acid Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Saudi Arabia Obeticholic Acid Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 27. South Africa Obeticholic Acid Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Turkey Obeticholic Acid Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Global Obeticholic Acid Drug Sales Market Share by Manufacturer in 2019
Figure 30. Global Obeticholic Acid Drug Revenue Market Share by Manufacturer in 2019
Figure 31. Top 3 Obeticholic Acid Drug Manufacturer (Revenue) Market Share in 2019
Figure 32. Top 6 Obeticholic Acid Drug Manufacturer (Revenue) Market Share in 2019
Figure 33. Key Manufacturer Market Share Trend
Figure 34. Global Obeticholic Acid Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 35. Global Obeticholic Acid Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 36. Global Obeticholic Acid Drug Revenue Market Share by Regions (2015-2020)
Figure 37. Global Obeticholic Acid Drug Revenue Market Share by Regions in 2018
Figure 38. North America Obeticholic Acid Drug Sales and Growth Rate (2015-2020)
Figure 39. Europe Obeticholic Acid Drug Sales and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Obeticholic Acid Drug Sales and Growth Rate (2015-2020)
Figure 41. South America Obeticholic Acid Drug Sales and Growth Rate (2015-2020)
Figure 42. Middle East & Africa Obeticholic Acid Drug Sales and Growth Rate (2015-2020)
Figure 43. North America Obeticholic Acid Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 44. North America Obeticholic Acid Drug Sales Market Share by Countries (2015-2020)
Figure 45. North America Obeticholic Acid Drug Sales Market Share by Countries in 2018
Figure 46. North America Obeticholic Acid Drug Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 47. North America Obeticholic Acid Drug Revenue Market Share by Countries in 2018
Figure 48. United States Obeticholic Acid Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 49. Canada Obeticholic Acid Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Mexico Obeticholic Acid Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Europe Obeticholic Acid Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 52. Europe Obeticholic Acid Drug Revenue Market Share by Countries (2015-2020)
Figure 53. Europe Obeticholic Acid Drug Revenue Market Share by Countries in 2019
Figure 54. Germany Obeticholic Acid Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 55. UK Obeticholic Acid Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 56. France Obeticholic Acid Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 57. Russia Obeticholic Acid Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Italy Obeticholic Acid Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Asia-Pacific Obeticholic Acid Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 60. Asia-Pacific Obeticholic Acid Drug Sales Market Share by Regions 2019
Figure 61. Asia-Pacific Obeticholic Acid Drug Revenue Market Share by Regions 2019
Figure 62. China Obeticholic Acid Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Japan Obeticholic Acid Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 64. Korea Obeticholic Acid Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 65. India Obeticholic Acid Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Southeast Asia Obeticholic Acid Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 67. South America Obeticholic Acid Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 68. South America Obeticholic Acid Drug Sales Market Share by Countries in 2019
Figure 69. South America Obeticholic Acid Drug Revenue Market Share by Countries in 2019
Figure 70. Brazil Obeticholic Acid Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 71. Argentina Obeticholic Acid Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 72. Middle East and Africa Obeticholic Acid Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. Middle East and Africa Obeticholic Acid Drug Sales Market Share by Countries in 2019
Figure 74. Middle East and Africa Obeticholic Acid Drug Revenue Market Share by Countries (2015-2020)
Figure 75. Middle East and Africa Obeticholic Acid Drug Revenue Market Share by Countries in 2019
Figure 76. Saudi Arabia Obeticholic Acid Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 77. Egypt Obeticholic Acid Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 78. Turkey Obeticholic Acid Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 79. South Africa Obeticholic Acid Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Global Obeticholic Acid Drug Sales and Growth Rate (2021-2025) (K Units)
Figure 81. Global Obeticholic Acid Drug Revenue and Growth Rate (2021-2025) (USD Million)
Figure 82. North America Sales Obeticholic Acid Drug Market Forecast (2021-2025) (K Units)
Figure 83. Europe Sales Obeticholic Acid Drug Market Forecast (2021-2025) (K Units)
Figure 84. Asia-Pacific Sales Obeticholic Acid Drug Market Forecast (2021-2025) (K Units)
Figure 85. South America Sales Obeticholic Acid Drug Market Forecast (2021-2025) (K Units)
Figure 86. Middle East & Africa Sales Obeticholic Acid Drug Market Forecast (2021-2025) (K Units)
Figure 87. Sales Channel: Direct Channel vs Indirect Channel
原発性胆汁性肝硬変治療薬の世界市場 2020年 Market Overview The global Primary Biliary Cirrhosis Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Primary Biliar…- 遊離脂肪酸受容体4の世界市場 2020年 Market Overview The global Free Fatty Acid Receptor 4 market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Free Fatty Acid Re…
- トール油脂肪酸の世界市場 2020年 Market Overview The Tall Oil Fatty Acid market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, t…
- 脂肪酸サプリメントの世界市場 2020年 Market Overview The global Fatty Acid Supplements market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Fatty Acid Supplements…
- 脂肪酸ポリグリセリンエステルの世界市場 2020年 Market Overview The Polyglycerol Esters of Fatty Acid market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain o…